Schürch M A, Rizzoli R, Slosman D, Vadas L, Vergnaud P, Bonjour J P
World Health Organization Collaborating Center for Osteoporosis and Bone Diseases and University Hospital, Geneva, Switzerland.
Ann Intern Med. 1998 May 15;128(10):801-9. doi: 10.7326/0003-4819-128-10-199805150-00002.
Elderly persons who have osteoporotic hip fracture are often undernourished, particularly with respect to protein. Protein malnutrition may contribute to the occurrence and outcome of hip fracture.
To investigate whether oral protein supplements benefit bone metabolism in patients with recent hip fracture.
6-month, randomized, double-blind, placebo-controlled trial with a 6-month post-treatment follow-up.
University orthopedic ward.
82 patients (mean age, 80.7 +/- 7.4 years) with recent osteoporotic hip fracture. Patients received calcium supplementation, 550 mg/d, and one dose of vitamin D, 200,000 IU (at baseline).
Protein supplementation, 20 g/d, or isocaloric placebo (among controls).
Bone mineral density, biochemical markers of bone remodeling, calciotropic hormone levels, biochemically evaluated nutritional and immunologic status, and muscle strength were measured every 6 months.
Compared with controls, patients who received protein supplements had significantly greater increases in serum levels of insulin-like growth factor-I (85.6% +/- 14.8% and 34.1% +/- 7.2% at 6 months; difference, 51.5 percentage points [95% CI, 18.6 to 84.4 percentage points]; P = 0.003) and an attenuation of the decrease in proximal femur bone mineral density (-2.29% +/- 0.75% and -4.71% +/- 0.77% at 12 months; difference, 2.42 percentage points [CI, 0.26 to 4.59 percentage points]; P = 0.029). Seven and 13 new vertebral deformities were found among patients who received protein supplements and controls, respectively (P > 0.2). Median stay in rehabilitation wards was shorter for patients who received protein supplements than for controls (33 days [CI, 29 to 56 days] and 54 days [CI, 44 to 62 days]; difference, 21 days [CI, 4 to 25 days]; P = 0.018).
Protein repletion after hip fracture was associated with increased serum levels of insulin-like growth factor-I, attenuation of proximal femur bone loss, and shorter stay in rehabilitation hospitals.
患有骨质疏松性髋部骨折的老年人往往营养不良,尤其是蛋白质方面。蛋白质营养不良可能会导致髋部骨折的发生及预后。
研究口服蛋白质补充剂是否有益于近期髋部骨折患者的骨代谢。
为期6个月的随机、双盲、安慰剂对照试验,并在治疗后进行6个月的随访。
大学骨科病房。
82例近期发生骨质疏松性髋部骨折的患者(平均年龄80.7±7.4岁)。患者每天补充550毫克钙,并在基线时服用一剂200,000国际单位的维生素D。
蛋白质补充剂,每天20克,或等热量安慰剂(对照组)。
每6个月测量骨密度、骨重塑的生化标志物、促钙激素水平、通过生化评估的营养和免疫状况以及肌肉力量。
与对照组相比,接受蛋白质补充剂的患者血清胰岛素样生长因子-I水平显著升高(6个月时分别为85.6%±14.8%和34.1%±7.2%;差异为51.5个百分点[95%可信区间,18.6至84.4个百分点];P = 0.003),股骨近端骨密度下降幅度减小(12个月时分别为-2.29%±0.75%和-4.71%±0.77%;差异为2.42个百分点[可信区间,0.26至4.59个百分点];P = 0.029)。接受蛋白质补充剂的患者和对照组分别发现7例和13例新的椎体畸形(P>0.2)。接受蛋白质补充剂的患者在康复病房的中位住院时间比对照组短(33天[可信区间,29至56天]和54天[可信区间,44至62天];差异为21天[可信区间,4至25天];P = 0.018)。
髋部骨折后补充蛋白质与血清胰岛素样生长因子-I水平升高、股骨近端骨质流失减少以及在康复医院的住院时间缩短有关。